Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/116813) titled 'A Study to Evaluate Skin Allergy and Irritation from Investigational Products in People with Sensitive Skin' on Sept. 1.

Study Type: Interventional

Study Design: Other Method of generating randomization sequence:Not Applicable Method of allocation concealment:Case Record Numbers Blinding and masking:Outcome Assessor Blinded

Primary Sponsor: Nanotech Biomedical

Intervention: Intervention1: Eczema Cream: 40 uL applied under an occlusive Finn Chamber for 24 plus or minus 2 hours. Nine induction applications will be given three times per week for three weeks. Intervention2: Psoriasis Cream: 40 uL applied...